The safety and efficacy of three acetylcholinesterase inhibitors (AChEIs)–donepezil, galantamine, and rivastigmine–in terms of cognitive improvement in AD have been confirmed in multicenter placebo-controlled double-blind randomized trials, and they have been widely used for the symptomatic relief of AD[3–5]. Here, ACHE is linked to Alzheimer disease.